Literature DB >> 35859183

Comparative evaluation of approach to cardiovascular care in neonatal encephalopathy undergoing therapeutic hypothermia.

Agnes Jermendy1, Patrick J McNamara2,3,4, Kata Kovacs1, Regan E Giesinger5,6, Andrea Lakatos7,8, Attila J Szabo1,9, Miklos Szabo1.   

Abstract

OBJECTIVE: To analyze the association between cardiovascular care and adverse outcome in infants undergoing therapeutic hypothermia for neonatal encephalopathy (NE). STUDY
DESIGN: This was a retrospective cohort study of 176 infants with NE and hypotension, admitted to the SickKids Hospital (Center A, n = 86) or Semmelweis University (Center B, n = 90). RESULT: The lowest systolic/diastolic blood pressures were comparable amongst centers; however, proportion of cardiovascular support was lower in Center A (51% vs 97% in Center B). Overall rate of death or abnormal MRI (adverse outcome) were comparable between centers, although pattern differed with more basal ganglia injury in Center B. A 24-hour longer duration of cardiovascular support increased the odds for adverse outcome by 14%.
CONCLUSION: We demonstrated that management of hemodynamic instability in infants with NE was markedly different in two high-volume NICUs and showed that longer duration of cardiovascular medication is an independent risk factor for adverse outcome.
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Year:  2022        PMID: 35859183     DOI: 10.1038/s41372-022-01459-6

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   3.225


  48 in total

Review 1.  Physiologic and pharmacologic considerations for hypothermia therapy in neonates.

Authors:  S Zanelli; M Buck; K Fairchild
Journal:  J Perinatol       Date:  2010-12-23       Impact factor: 2.521

Review 2.  Physiological responses to hypothermia.

Authors:  Thomas Wood; Marianne Thoresen
Journal:  Semin Fetal Neonatal Med       Date:  2014-11-08       Impact factor: 3.926

3.  Hypoxic-Ischemic Encephalopathy and Therapeutic Hypothermia: The Hemodynamic Perspective.

Authors:  Regan E Giesinger; Liane J Bailey; Poorva Deshpande; Patrick J McNamara
Journal:  J Pediatr       Date:  2016-10-11       Impact factor: 4.406

4.  Cardiovascular changes during mild therapeutic hypothermia and rewarming in infants with hypoxic-ischemic encephalopathy.

Authors:  M Thoresen; A Whitelaw
Journal:  Pediatrics       Date:  2000-07       Impact factor: 7.124

Review 5.  Hydrocortisone Dosing for Hypotension in Newborn Infants: Less Is More.

Authors:  Kristi L Watterberg
Journal:  J Pediatr       Date:  2016-05-04       Impact factor: 4.406

6.  Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy.

Authors:  Jennifer J Kurinczuk; Melanie White-Koning; Nadia Badawi
Journal:  Early Hum Dev       Date:  2010-06-16       Impact factor: 2.079

7.  Impaired Right Ventricular Performance Is Associated with Adverse Outcome after Hypoxic Ischemic Encephalopathy.

Authors:  Regan E Giesinger; Amr I El Shahed; Michael P Castaldo; Colm R Breatnach; Vann Chau; Hilary E Whyte; Afif F El-Khuffash; Luc Mertens; Patrick J McNamara
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

8.  Hydrocortisone administration for the treatment of refractory hypotension in critically ill newborns.

Authors:  C F W Baker; J D E Barks; C Engmann; D M Vazquez; C R Neal; R E Schumacher; V Bhatt-Mehta
Journal:  J Perinatol       Date:  2008-03-13       Impact factor: 2.521

9.  Moderate hypothermia to treat perinatal asphyxial encephalopathy.

Authors:  Denis V Azzopardi; Brenda Strohm; A David Edwards; Leigh Dyet; Henry L Halliday; Edmund Juszczak; Olga Kapellou; Malcolm Levene; Neil Marlow; Emma Porter; Marianne Thoresen; Andrew Whitelaw; Peter Brocklehurst
Journal:  N Engl J Med       Date:  2009-10-01       Impact factor: 91.245

10.  Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000.

Authors:  Li Liu; Hope L Johnson; Simon Cousens; Jamie Perin; Susana Scott; Joy E Lawn; Igor Rudan; Harry Campbell; Richard Cibulskis; Mengying Li; Colin Mathers; Robert E Black
Journal:  Lancet       Date:  2012-05-11       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.